See also this year's filing and all EDGAR filings for this company.
PDF Report 0000847464_2018_SPRING_PHARMACEUTICAL_GROUP_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000847464')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000847464, SPRING PHARMACEUTICAL GROUP INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,042,758 |
| 2 | PropertyPlantAndEquipmentNet | 14,487,135 |
| 3 | remainder_Assets | 63,757,133 |
| 4 | LiabilitiesCurrent | 2,985,545 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 43,262,557 |
| 11 | remainder_Revenues | 56,463,164 |
| 12 | remainder_NetIncome | 54,672 |
| 13 | remainder_ComprehensiveNetIncome | -8,428,993 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 90,287,026 |
| 1 | Liabilities | 2,985,545 |
| 2 | Expenses | 43,262,557 |
| 3 | Revenues | 56,463,164 |
| 4 | StockholdersEquity | 87,301,481 |
| 5 | NetIncome | 13,255,279 |
| 6 | ComprehensiveNetIncome | 9,040,782 |
| 7 | BaseVar | 100,740,978 |
| 8 | EconomicCapitalRatio | 3.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
